selinexor,Ruxolitinib
karyopharm therapeutics,novartis,incyte
['selinexor', '$kpti']
karyopharm announces presentation of updated phase 1 selinexor data in patients with treatment-na ve myelofibrosis at aacr 2023 $kpti 
Real-Time News, Market Data, Insider Trades, and Stock Quotes for Biotech, Pharma, Medical, and Healthcare Stocks @ https://t.co/Oqp6BRBKy2